GALT.OB Insider Trading Activity and SEC Form 4 Filings
GALT.OB insider trading summary
No open-market insider purchases or sales of Galectin Therapeutics Inc (GALT.OB) have been reported on SEC Form 4 in the past 12 months.
Latest GALT.OB insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Oct 18, 2011 | Marc Rubin | Director | Buy | $19K (20,000 @ $0.96) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.